MARK STOLPER Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK STOLPER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK STOLPER. MARK STOLPER is an Executive VP and CFO in RadNet, Inc. ($PMDX) and a Director in RTI SURGICAL, INC. ($RTIX) and a Director in Coherus BioSciences, Inc. ($CHRS) and a Director in RTI Surgical Holdings, Inc. ($RTIX).
Address: 850 MORAGA DRIVE LOS ANGELES 90049 CA
Companies in which MARK STOLPER is an Insider
Coherus BioSciences, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MARK STOLPER: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 25 2021
$CHRS Market Capitalization: $1.03B
$CHRS Previous Close: $26.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RadNet, Inc.
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of MARK STOLPER: Executive VP and CFO
Holdings: 104,239 shares
Latest Transaction: Jan 06 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RTI SURGICAL, INC.
Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
Position of MARK STOLPER: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 11 2019
$RTIX Market Capitalization: $189.01M
$RTIX Previous Close: $3.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SURGALIGN HOLDINGS, INC.
Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
Position of MARK STOLPER: Director
Holdings: 165,946 shares
Latest Transaction: May 10 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MARK STOLPER
Sentiment: All, CHRS, RDNT, RTIX, RTIX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 25 2021 | CHRS | Coherus BioScience ... | STOLPER MARK | Director | Option Exercise | A | 13.48 | 20,000 | 269,600 | 20,000 | |
| May 10 2021 | RTIX | SURGALIGN HOLDINGS ... | STOLPER MARK | Director | Grant | A | 0.00 | 57,803 | 0 | 165,946 | 108.1 K to 165.9 K (+53.45 %) |
| Feb 02 2021 | RTIX | SURGALIGN HOLDINGS ... | STOLPER MARK | Director | Buy | P | 1.50 | 16,667 | 25,001 | 108,143 | 91.5 K to 108.1 K (+18.22 %) |
| Jan 07 2021 | CHRS | Coherus BioScience ... | STOLPER MARK | Director | Option Exercise | A | 16.85 | 40,000 | 674,000 | 40,000 | |
| Jan 06 2021 | RDNT | RadNet, Inc. | STOLPER MARK | Executive VP and CF ... | Option Exercise | A | 0.00 | 19,317 | 0 | 19,317 | |
| Mar 02 2020 | RTIX | RTI Surgical Holdi ... | STOLPER MARK | Director | Grant | A | 0.00 | 24,692 | 0 | 91,476 | 66.8 K to 91.5 K (+36.97 %) |
| Jan 10 2020 | RDNT | RadNet, Inc. | STOLPER MARK | Executive VP and CF ... | Option Exercise | A | 20.43 | 11,625 | 237,499 | 33,354 |